CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Duchesnay Inc. v. Mylan Pharmaceuticals Inc.

1:15-cv-00385

Overview

Case Number 1:15-cv-00385
Filing Date 2015-05-13
Status Terminated
Termination Date 2016-07-15
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Mylan Pharmaceuticals Inc. Operating Company

Represented By

5 Attorneys Listed

Mary Matterer

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

Timothy H. Kratz

Email: tkratz@kratzandbarry.com

Michael F. Nullet

UNDELIVERABLE EMAIL 6/21/2016

Karen L. Carroll

Email: karencarroll@parkerpoe.com

George J. Barry , III

Email: gbarry@kratzandbarry.com

Plaintiff

Duchesnay USA Inc. Operating Company

Represented By

4 Attorneys Listed

Thomas J. Curry

Labaton Sucharow LLP

Tel: +1 (302) 573-6956

300 Delaware Avenue, Suite 1340

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Duchesnay Inc. Operating Company

Represented By

4 Attorneys Listed

Thomas J. Curry

Labaton Sucharow LLP

Tel: +1 (302) 573-6956

300 Delaware Avenue, Suite 1340

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 16 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (16): πŸ‡¨πŸ‡¦ Canada CN πŸ‡©πŸ‡ͺ Germany πŸ‡ͺπŸ‡Ί Europe FR GB πŸ‡―πŸ‡΅ Japan KR πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6340695
Rapid onset formulation
Filed: 2001-06-21
Issued: 2002-01-22
Expired (Term Ended)
Expires: 2021-06-21
US7560122
Pharmaceutical dosage form bearing pregnancy-friendly indicia
Filed: 2003-07-01
Issued: 2009-07-14
Expired (Term Ended) +576d PTA
Expires: 2025-01-27

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT filed against Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1722199.) - filed by Duchesnay Inc., Duchesnay USA Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 05/14/2015)

Entry #1 • 2015-05-13
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 05/14/2015)

Entry #2 • 2015-05-13
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 04/14/2015. Date of Expiration of Patent: 06/21/2021.Thirty Month Stay Deadline: 10/14/2017. (dmp, ) (Entered: 05/14/2015)

Entry #3 • 2015-05-13
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,340,695 B1;. (dmp, ) (Entered: 05/14/2015)

Entry #4 • 2015-05-13
1
Pleading / Complaint

SUMMONS Returned Executed by Duchesnay Inc., Duchesnay USA Inc.. Mylan Pharmaceuticals Inc. served on 5/14/2015, answer due 6/4/2015. (Graham, Mary) (Entered: 05/14/2015)

Entry #5 • 2015-05-14
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc